CutisPharma was a proud sponsor of IDWeek 2018 for the second year! This is an inclusive meeting that offers access to internationally recognized leaders in the field and the opportunity to network with the most highly respected health professionals in infectious diseases, including HIV. This was a great place for our team to showcase our newly designed 20×40 FIRVANQ™ booth. Our team stands behind the Infectious Diseases Society of Americas (IDSA) purpose to improve the health of individuals, communities and society by promoting excellence in patient care, education, research, public health and prevention relating to infectious diseases.
Along with IDSA, our team stands behind SHEA’s mission to prevent and control healthcare-associated infections and advance the field of healthcare epidemiology. With CutisPharma’s commercial team in attendance at IDWeek, we were able to feature our FDA approved vancomycin hydrochloride oral solution (FIRVANQ™) and its availability.